Development of Objective Measures for Use in Pediatric Drug Trials for Psychiatric and Neurodevelopmental Disorders

Development of Objective Measures for Use in Pediatric Drug Trials for Psychiatric and Neurodevelopmental Disorders

Presenter Meg Grabb, Ph.D.Division of Translational Research Goal This effort aims to stimulate research in a major gap area in pediatric psychopharmacology for psychiatric and neurodevelopmental disorders, by encouraging the development of... Read more »
Development of Objective Measures for Use in Pediatric Drug Trials for Psychiatric and Neurodevelopmental Disorders

Discovery of Proteins and Metabolites Implicated in Mental Illness and Neurodevelopmental Disorders

Presenter Laurie Nadler, Ph.D. Division of Neuroscience and Basic Behavioral Science Goal The goal of this concept is to determine changes in protein expression, post-translational modifications, protein-protein interactions, and/or metabolite abundance in human... Read more »
Disability, Equity, and Mental Health Research Webinar Series: Improving Mental Health Equity for Individuals with Neurodevelopmental Conditions: An Examination of Risk and Protective Factors and Potential Interventions

Disability, Equity, and Mental Health Research Webinar Series: Improving Mental Health Equity for Individuals with Neurodevelopmental Conditions: An Examination of Risk and Protective Factors and Potential Interventions

Date and Time October 10, 20241:00–2:30 p.m. ET Overview Emerging research shows that depression, suicidality, and other mental health disorders are more common among autistic people and those with neurodevelopmental conditions compared to... Read more »
Home Privacy Policy Terms Of Use Anti Spam Policy Contact Us Affiliate Disclosure Amazon Affiliate Disclaimer DMCA Earnings Disclaimer